Screening HIV-positive pregnant women for antiretroviral therapy

Utility of self-reported symptoms

Ruby H N Nguyen, Stephen J Gange, David Serwadda, Godfrey Kigozi, Noah Kiwanuka, Nelson K. Sewankambo, Fred Wabwire-Mangen, Thomas C Quinn, Maria J Wawer, Ronald H Gray

Research output: Contribution to journalArticle

Abstract

In developing countries, Mother-to-Child Transmission-Plus programmes propose to identify lifelong antiretroviral therapy (ART)-eligible women during antenatal care. Identification using AIDS-related symptoms is the most feasible screening procedure in resource-limited settings. It is not known if symptomatology in pregnant women is correlated with clinical criteria for ART initiation based on CD4+ cell count or HIV-1 viral load. In this population of HIV-positive pregnant women from Rakai District, Uganda, 8-23% were eligible for treatment by CD4+ cell count criteria, and <1% met WHO staging criteria for AIDS. Using one or more symptoms to predict CD4+ cell count <350 cells/mm3, sensitivity was 100%, specificity 11%, positive predictive value (PPV) 25%, and negative predictive value (NPV) 100%. When using one or more symptoms to predict viral load ≥100,000 cps/mL, sensitivity was 100%, specificity 10%, PPV 6%, and NPV 100%. Initiation of treatment based on self-reported symptoms will over-treat because the majority of pregnant women with symptoms would not be eligible for treatment under current guidelines, but asymptomatic pregnant women are unlikely to require ART.

Original languageEnglish (US)
Pages (from-to)112-115
Number of pages4
JournalInternational Journal of STD and AIDS
Volume17
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

Pregnant Women
HIV
CD4 Lymphocyte Count
Viral Load
Acquired Immunodeficiency Syndrome
Therapeutics
Uganda
Prenatal Care
Developing Countries
HIV-1
Mothers
Guidelines
Population

Keywords

  • ART
  • HIV
  • Pregnant
  • Symptomatology
  • Viral load

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Immunology

Cite this

Screening HIV-positive pregnant women for antiretroviral therapy : Utility of self-reported symptoms. / Nguyen, Ruby H N; Gange, Stephen J; Serwadda, David; Kigozi, Godfrey; Kiwanuka, Noah; Sewankambo, Nelson K.; Wabwire-Mangen, Fred; Quinn, Thomas C; Wawer, Maria J; Gray, Ronald H.

In: International Journal of STD and AIDS, Vol. 17, No. 2, 02.2006, p. 112-115.

Research output: Contribution to journalArticle

Nguyen, Ruby H N ; Gange, Stephen J ; Serwadda, David ; Kigozi, Godfrey ; Kiwanuka, Noah ; Sewankambo, Nelson K. ; Wabwire-Mangen, Fred ; Quinn, Thomas C ; Wawer, Maria J ; Gray, Ronald H. / Screening HIV-positive pregnant women for antiretroviral therapy : Utility of self-reported symptoms. In: International Journal of STD and AIDS. 2006 ; Vol. 17, No. 2. pp. 112-115.
@article{6051d9a7259c41f9b9970055b99eee06,
title = "Screening HIV-positive pregnant women for antiretroviral therapy: Utility of self-reported symptoms",
abstract = "In developing countries, Mother-to-Child Transmission-Plus programmes propose to identify lifelong antiretroviral therapy (ART)-eligible women during antenatal care. Identification using AIDS-related symptoms is the most feasible screening procedure in resource-limited settings. It is not known if symptomatology in pregnant women is correlated with clinical criteria for ART initiation based on CD4+ cell count or HIV-1 viral load. In this population of HIV-positive pregnant women from Rakai District, Uganda, 8-23{\%} were eligible for treatment by CD4+ cell count criteria, and <1{\%} met WHO staging criteria for AIDS. Using one or more symptoms to predict CD4+ cell count <350 cells/mm3, sensitivity was 100{\%}, specificity 11{\%}, positive predictive value (PPV) 25{\%}, and negative predictive value (NPV) 100{\%}. When using one or more symptoms to predict viral load &ge;100,000 cps/mL, sensitivity was 100{\%}, specificity 10{\%}, PPV 6{\%}, and NPV 100{\%}. Initiation of treatment based on self-reported symptoms will over-treat because the majority of pregnant women with symptoms would not be eligible for treatment under current guidelines, but asymptomatic pregnant women are unlikely to require ART.",
keywords = "ART, HIV, Pregnant, Symptomatology, Viral load",
author = "Nguyen, {Ruby H N} and Gange, {Stephen J} and David Serwadda and Godfrey Kigozi and Noah Kiwanuka and Sewankambo, {Nelson K.} and Fred Wabwire-Mangen and Quinn, {Thomas C} and Wawer, {Maria J} and Gray, {Ronald H}",
year = "2006",
month = "2",
doi = "10.1258/095646206775455801",
language = "English (US)",
volume = "17",
pages = "112--115",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Screening HIV-positive pregnant women for antiretroviral therapy

T2 - Utility of self-reported symptoms

AU - Nguyen, Ruby H N

AU - Gange, Stephen J

AU - Serwadda, David

AU - Kigozi, Godfrey

AU - Kiwanuka, Noah

AU - Sewankambo, Nelson K.

AU - Wabwire-Mangen, Fred

AU - Quinn, Thomas C

AU - Wawer, Maria J

AU - Gray, Ronald H

PY - 2006/2

Y1 - 2006/2

N2 - In developing countries, Mother-to-Child Transmission-Plus programmes propose to identify lifelong antiretroviral therapy (ART)-eligible women during antenatal care. Identification using AIDS-related symptoms is the most feasible screening procedure in resource-limited settings. It is not known if symptomatology in pregnant women is correlated with clinical criteria for ART initiation based on CD4+ cell count or HIV-1 viral load. In this population of HIV-positive pregnant women from Rakai District, Uganda, 8-23% were eligible for treatment by CD4+ cell count criteria, and <1% met WHO staging criteria for AIDS. Using one or more symptoms to predict CD4+ cell count <350 cells/mm3, sensitivity was 100%, specificity 11%, positive predictive value (PPV) 25%, and negative predictive value (NPV) 100%. When using one or more symptoms to predict viral load &ge;100,000 cps/mL, sensitivity was 100%, specificity 10%, PPV 6%, and NPV 100%. Initiation of treatment based on self-reported symptoms will over-treat because the majority of pregnant women with symptoms would not be eligible for treatment under current guidelines, but asymptomatic pregnant women are unlikely to require ART.

AB - In developing countries, Mother-to-Child Transmission-Plus programmes propose to identify lifelong antiretroviral therapy (ART)-eligible women during antenatal care. Identification using AIDS-related symptoms is the most feasible screening procedure in resource-limited settings. It is not known if symptomatology in pregnant women is correlated with clinical criteria for ART initiation based on CD4+ cell count or HIV-1 viral load. In this population of HIV-positive pregnant women from Rakai District, Uganda, 8-23% were eligible for treatment by CD4+ cell count criteria, and <1% met WHO staging criteria for AIDS. Using one or more symptoms to predict CD4+ cell count <350 cells/mm3, sensitivity was 100%, specificity 11%, positive predictive value (PPV) 25%, and negative predictive value (NPV) 100%. When using one or more symptoms to predict viral load &ge;100,000 cps/mL, sensitivity was 100%, specificity 10%, PPV 6%, and NPV 100%. Initiation of treatment based on self-reported symptoms will over-treat because the majority of pregnant women with symptoms would not be eligible for treatment under current guidelines, but asymptomatic pregnant women are unlikely to require ART.

KW - ART

KW - HIV

KW - Pregnant

KW - Symptomatology

KW - Viral load

UR - http://www.scopus.com/inward/record.url?scp=33644529994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644529994&partnerID=8YFLogxK

U2 - 10.1258/095646206775455801

DO - 10.1258/095646206775455801

M3 - Article

VL - 17

SP - 112

EP - 115

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 2

ER -